NK3 receptor antagonist

This page covers all NK3 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NK3 receptor (neurokinin-3 receptor).

Targets

NK3 receptor (neurokinin-3 receptor)

Phase 3 pipeline (1)

• Elinzanetant (BAY3427080) · Bayer · Women's Health / Endocrinology
  Elinzanetant is a neurokinin-3 (NK3) receptor antagonist that reduces vasomotor symptoms by blocking neurokinin signaling in the hypothalamus.

Patent intelligence

• nk3 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates